Wuhan Keqian Biology Co.,Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 202.66 million compared to CNY 318.93 million a year ago. Revenue was CNY 202.66 million compared to CNY 318.93 million a year ago. Net income was CNY 90.77 million compared to CNY 168.95 million a year ago. Basic earnings per share from continuing operations was CNY 0.2 compared to CNY 0.36 a year ago. Diluted earnings per share from continuing operations was CNY 0.2 compared to CNY 0.36 a year ago.